Araujo AB, ODonnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89:59206. https://doi.org/10.1210/jc.2003-031719

Article CAS PubMed Google Scholar

Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60:7629. https://doi.org/10.1111/j.1742-1241.2006.00992.x

Article CAS PubMed Google Scholar

Thirumavalavan N, Scovell JM, Link RE, Lamb DJ, Lipshultz LI. Does solid organ transplantation affect male reproduction? Eur Urol Focus. 2018;4:30710. https://doi.org/10.1016/j.euf.2018.08.012

Article PubMed PubMed Central Google Scholar

Carrero JJ, Qureshi AR, Parini P, Arver S, Lindholm B, Brny P, et al. Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol. 2009;20:61320. https://doi.org/10.1681/ASN.2008060664

Article CAS PubMed PubMed Central Google Scholar

Wachterman MW, OHare AM, Rahman O-K, Lorenz KA, Marcantonio ER, Alicante GK, et al. One-year mortality after dialysis initiation among older adults. JAMA Intern Med. 2019;179:98790. https://doi.org/10.1001/jamainternmed.2019.0125

Article PubMed PubMed Central Google Scholar

Kazemeini SM, Mogharabian N, Asadpour A, Naderi G, Kasaeian A, Mousavi A. The effect of renal transplant on hypogonadism and erectile dysfunction due to end-stage renal disease. Saudi J Kidney Dis Transplant. 2021;32:9238. https://doi.org/10.4103/1319-2442.338303

Article Google Scholar

Akbari F, Alavi M, Esteghamati A, Mehrsai A, Djaladat H, Zohrevand R, et al. Effect of renal transplantation on sperm quality and sex hormone levels. BJU Int. 2003;92:2813. https://doi.org/10.1046/j.1464-410x.2003.04323.x

Article CAS PubMed Google Scholar

Reinhardt W, Kbber H, Dolff S, Benson S, Fhrer D, Tan S. Rapid recovery of hypogonadism in male patients with end stage renal disease after renal transplantation. Endocrine. 2018;60:15966. https://doi.org/10.1007/s12020-018-1543-2

Article CAS PubMed Google Scholar

Saha M-T, Saha HHT, Niskanen LK, Salmela KT, Pasternack AI. Time course of serum prolactin and sex hormones following successful renal transplantation. Nephron. 2002;92:7357. https://doi.org/10.1159/000064079

Article CAS PubMed Google Scholar

Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold J. Low testosterone at time of transplantation is independently associated with poor patient and graft survival in male renal transplant recipients. J Urol. 2014;192:116871. https://doi.org/10.1016/j.juro.2014.03.102

Article CAS PubMed Google Scholar

UNOS Data and Transplant Statistics | Organ Donation Data. UNOS. https://unos.org/data/. Accessed 3 February 2024.

Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389:10717. https://doi.org/10.1056/NEJMoa2215025

Article CAS PubMed Google Scholar

Antonucci M, Palermo G, Recupero SM, Bientinesi R, Presicce F, Foschi N, et al. Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients. Arch Ital Urol Androl. 2016;87:299305. https://doi.org/10.4081/aiua.2015.4.299

Article PubMed Google Scholar

Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011;123:1727. https://doi.org/10.3810/pgm.2011.05.2280

Article PubMed Google Scholar

Cha J, Han D. Health-related quality of life based on comorbidities among patients with end-stage renal disease. Osong Public Health Res Perspect. 2020;11:194200. https://doi.org/10.24171/j.phrp.2020.11.4.08

Article PubMed PubMed Central Google Scholar

Albaaj F, Sivalingham M, Haynes P, McKinnon G, Foley RN, Waldek S, et al. Prevalence of hypogonadism in male patients with renal failure. Postgrad Med J. 2006;82:6936. https://doi.org/10.1136/pgmj.2006.045963

Article CAS PubMed PubMed Central Google Scholar

Balczar-Hernndez L, Mendoza-Zubieta V, Gonzlez-Virla B, Gonzlez-Garca B, Osorio-Olvera M, Pealoza-Juarez JU, et al. Hypothalamic-pituitary-gonadal axis disturbance and its association with insulin resistance in kidney transplant recipients. J Bras Nefrol. 2023;45:7783. https://doi.org/10.1590/2175-8239-JBN-2021-0250en

Article PubMed Google Scholar

Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology. 2006;11:3641. https://doi.org/10.1111/j.1440-1797.2006.00541.x

Article PubMed Google Scholar

Wibullaksanakul S, Handelsman DJ. Regulation of hypothalamic gonadotropin-releasing hormone secretion in experimental uremia: in vitro studies. Neuroendocrinology. 1991;54:3538. https://doi.org/10.1159/000125913

Article CAS PubMed Google Scholar

Dong QH, Handelsman DJ. Regulation of pulsatile luteinizing hormone secretion in experimental uremia. Endocrinology. 1991;128:121822. https://doi.org/10.1210/endo-128-3-1218

Article CAS PubMed Google Scholar

Lim VS, Henriquez C, Sievertsen G, Frohman LA. Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation. Ann Intern Med. 1980;93:217. https://doi.org/10.7326/0003-4819-93-1-21

Article CAS PubMed Google Scholar

Prem AR, Punekar SV, Kalpana M, Kelkar AR, Acharya VN. Male reproductive function in uraemia: efficacy of haemodialysis and renal transplantation. Br J Urol. 1996;78:6358. https://doi.org/10.1046/j.1464-410x.1996.14624.x

Article CAS PubMed Google Scholar

Levitan D, Moser SA, Goldstein DA, Kletzky OA, Lobo RA, Massry SG. Disturbances in the hypothalamic-pituitary-gonadal axis in male patients with acute renal failure. Am J Nephrol. 1984;4:99106. https://doi.org/10.1159/000166785

Article CAS PubMed Google Scholar

Distiller LA, Morley JE, Sagel J, Pokroy M, Rabkin R. Pituitary-gonadal function in chronic renal failure: the effect of luteinizing hormone-releasing hormone and the influence of dialysis. Metabolism. 1975;24:71120. https://doi.org/10.1016/0026-0495(75)90039-6

Article CAS PubMed Google Scholar

Biasioli S, Mazzali A, Foroni R, DAndrea G, Feriani M, Chiaramonte S, et al. Chronobiological variations of prolactin (PRL) in chronic renal failure (CRF). Clin Nephrol. 1988;30:8692.

CAS PubMed Google Scholar

Carrero JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, et al. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol. 2012;7:20715. https://doi.org/10.2215/CJN.06840711

Article CAS PubMed PubMed Central Google Scholar

Adachi N, Lei B, Deshpande G, Seyfried FJ, Shimizu I, Nagaro T, et al. Uraemia suppresses central dopaminergic metabolism and impairs motor activity in rats. Intensive Care Med. 2001;27:165560. https://doi.org/10.1007/s001340101067

Article CAS PubMed Google Scholar

Sievertsen GD, Lim VS, Nakawatase C, Frohman LA. Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab. 1980;50:84652. https://doi.org/10.1210/jcem-50-5-846

Article CAS PubMed Google Scholar

Carrero JJ, Qureshi AR, Nakashima A, Arver S, Parini P, Lindholm B, et al. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol Dial Transplant. 2011;26:18490. https://doi.org/10.1093/ndt/gfq397

Article CAS PubMed Google Scholar

Foresta C, Caretta N, Lana A, De Toni L, Biagioli A, Ferlin A, et al. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metab. 2006;91:4599602. https://doi.org/10.1210/jc.2006-0763

Article CAS PubMed Google Scholar

Nilsson E, Stenvinkel P, Liu S, Stedman MR, Chertow GM, Floege J. Serum testosterone concentrations and outcomes in hemodialysis patients enrolled in the EVOLVE trial. Nephrol Dial Transplant. 2023;38:151927. https://doi.org/10.1093/ndt/gfac278

Article CAS PubMed Google Scholar

Rymarz A, Matyjek A, Gomka M, Niemczyk S. Lean tissue index and body cell mass can be predictors of low free testosterone levels in men on hemodialysis. J Ren Nutr. 2019;29:52935. https://doi.org/10.1053/j.jrn.2019.03.078

Article CAS PubMed Google Scholar

Cobo G, Gallar P, Di Gioia C, Garca Lacalle C, Camacho R, Rodriguez I, et al. Hypogonadism associated with muscle atrophy, physical inactivity and ESA hyporesponsiveness in men undergoing haemodialysis. Nefrologia. 2017;37:5460. https://doi.org/10.1016/j.nefro.2016.04.009

Article PubMed Google Scholar

Park MG, Koo HS, Lee B. Characteristics of testosterone deficiency syndrome in men with chronic kidney disease and male renal transplant recipients: a cross-sectional study. Transplant Proc. 2013;45:29704. https://doi.org/10.1016/j.transproceed.2013.08.087

Article CAS PubMed Google Scholar

Skiba R, Rymarz A, Matyjek A, Dymus J, Woniak-Kosek A, Syryo T, et al. Testosterone replacement therapy in chronic kidney disease patients. Nutrients. 2022;14:3444. https://doi.org/10.3390/nu14163444

Article CAS PubMed PubMed Central Google Scholar

Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200:42332. https://doi.org/10.1016/j.juro.2018.03.115

Article PubMed Google Scholar

Brock G, Heiselman D, Maggi M, Kim SW, Rodrguez Vallejo JM, Behre HM, et al. Effect of testosterone solution 2% on testosterone concentration, sex drive and energy in hypogonadal men: results of a placebo controlled study. J Urol. 2016;195:699705. https://doi.org/10.1016/j.juro.2015.10.083

Article CAS PubMed Google Scholar

Maggi M, Heiselman D, Knorr J, Iyengar S, Paduch DA, Donatucci CF. Impact of testosterone solution 2% on ejaculatory dysfunction in hypogonadal men. J Sex Med. 2016;13:12206. https://doi.org/10.1016/j.jsxm.2016.05.012

Article PubMed Google Scholar

Roy CN, Snyder PJ, Stephens-Shields AJ, Artz AS, Bhasin S, Cohen HJ, et al. Association of testosterone levels with anemia in older men: a controlled clinical trial. JAMA Intern Med. 2017;177:48090. https://doi.org/10.1001/jamainternmed.2016.9540

Article PubMed PubMed Central Google Scholar

Svartberg J, Agledahl I, Figenschau Y, Sildnes T, Waterloo K, Jorde R. Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. Int J Impot Res. 2008;20:37887. https://doi.org/10.1038/ijir.2008.19

Article CAS PubMed Google Scholar

Cherrier MM, Anderson K, Shofer J, Millard S, Matsumoto AM. Testosterone treatment of men with mild cognitive impairment and low testosterone levels. Am J Alzheimers Dis Other Demen. 2015;30:42130. https://doi.org/10.1177/1533317514556874

Article CAS PubMed Google Scholar

Vaughan C, Goldstein FC, Tenover JL. Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone. J Androl. 2007;28:87582. https://doi.org/10.2164/jandrol.107.002931

Article CAS PubMed Google Scholar

Grossmann M, Hoermann R, Wittert G, Yeap BB. Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Clin Endocrinol. 2015;83:34451. https://doi.org/10.1111/cen.12664

Article CAS Google Scholar

Barton CH, Mirahmadi MK, Vaziri ND. Effects of long-term testosterone administration on pituitary-testicular axis in end-stage renal failure. Nephron. 1982;31:614. https://doi.org/10.1159/000182618

Article CAS PubMed Google Scholar

van Coevorden A, Stolear JC, Dhaene M, van Herweghem JL, Mockel J. Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients. Clin Nephrol. 1986;26:4854.

PubMed Google Scholar

Pechersky AV, Mazurov VI, Semiglazov VF, Karpischenko AI, Mikhailichenko VV, Udintsev AV. Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume. Int J Androl. 2002;25:11925. https://doi.org/10.1046/j.1365-2605.2002.00335.x

Article CAS PubMed Google Scholar

Pizzol D, Xiao T, Yang L, Demurtas J, McDermott D, Garolla A, et al. Prevalence of erectile dysfunction in patients with chronic kidney disease: a systematic review and meta-analysis. Int J Impot Res. 2021;33:50815. https://doi.org/10.1038/s41443-020-0295-8

Article PubMed Google Scholar

Lawrence IG, Price DE, Howlett TA, Harris KP, Feehally J, Walls J. Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis. 1998;31:3139. https://doi.org/10.1053/ajkd.1998.v31.pm9469503

Article CAS PubMed Google Scholar

Chatterjee R, Wood S, McGarrigle HH, Lees WR, Ralph DJ, Neild GH. A novel therapy with testosterone and sildenafil for erectile dysfunction in patients on renal dialysis or after renal transplantation. J Fam Plann Reprod Health Care. 2004;30:8890. https://doi.org/10.1783/147118904322995438

Article PubMed Google Scholar

Cunningham G, Belkoff L, Brock G, Efros M, Gittelman M, Carrara D, et al. Efficacy and safety of a new topical testosterone replacement gel therapy for the treatment of male hypogonadism. Endocr Pract. 2017;23:55765. https://doi.org/10.4158/EP161665.OR

Article PubMed Google Scholar

Gronski MA, Grober ED, Gottesman IS, Ormsby RW, Bryson N. Efficacy of nasal testosterone gel (Natesto) stratified by baseline endogenous testosterone levels. J Endocr Soc. 2019;3:165262. https://doi.org/10.1210/js.2019-00183

Go here to read the rest:
Testosterone deficiency in men with end stage renal disease and kidney transplantation: a narrative review ... - Nature.com

Comments are closed.